By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Lovastatin

Lovastatin

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|594 words

Lovastatin Drug Profile

What is Lovastatin?

Lovastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels in the blood and reduce the risk of cardiovascular disease in patients with elevated cholesterol. Lovastatin was one of the first statins developed and remains an important medication for managing cholesterol disorders.

Uses

Lovastatin is prescribed for several cardiovascular conditions:

  • Primary hypercholesterolemia: Treatment of high cholesterol levels when diet and lifestyle changes alone are insufficient
  • Mixed dyslipidemia: Management of elevated cholesterol and triglyceride levels, particularly when LDL cholesterol is high
  • Primary prevention of cardiovascular disease: Reducing heart attack and stroke risk in patients with multiple cardiovascular risk factors
  • Secondary prevention: Preventing future cardiovascular events in patients with established heart disease
  • Familial hypercholesterolemia: Treatment of inherited forms of high cholesterol, including heterozygous familial hypercholesterolemia

How it works

Lovastatin works by inhibiting HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By blocking this enzyme, lovastatin reduces the liver’s ability to manufacture cholesterol, forcing the body to remove more cholesterol from the bloodstream. This mechanism effectively lowers total cholesterol, LDL (“bad”) cholesterol, and triglycerides while modestly increasing HDL (“good”) cholesterol levels.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Digestive issues (nausea, constipation, diarrhea)
  • Dizziness
  • Skin rash
  • Fatigue
  • Abdominal pain
  • Sleep disturbances

Serious side effects that require immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (signs of rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain
  • Unexplained fatigue or fever

Warnings and precautions

  • Liver function monitoring: Regular liver enzyme tests are necessary as lovastatin can cause liver damage in rare cases
  • Muscle complications: Risk of myopathy and rhabdomyolysis increases with higher doses and certain drug interactions
  • Pregnancy and breastfeeding: Lovastatin is contraindicated during pregnancy and breastfeeding as it may harm fetal development
  • Active liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not use lovastatin
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require lower doses

Interactions

Lovastatin has several important drug interactions:

  • Gemfibrozil: Significantly increases risk of muscle toxicity and should be avoided
  • Cyclosporine: Increases lovastatin levels and muscle toxicity risk
  • Azole antifungals (ketoconazole, itraconazole): Inhibit lovastatin metabolism, increasing toxicity risk
  • Macrolide antibiotics (erythromycin, clarithromycin): Can increase lovastatin levels and side effects
  • Protease inhibitors: HIV medications that significantly increase lovastatin concentrations
  • Grapefruit juice: Contains compounds that can increase lovastatin levels and should be limited
  • Warfarin: Lovastatin may enhance anticoagulant effects, requiring closer monitoring
  • Digoxin: Statin therapy may increase digoxin levels slightly

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing for lovastatin ranges from 20 to 80 mg taken once daily with the evening meal, as cholesterol production is highest at night. Most patients start with 20 mg daily, with doses adjusted based on cholesterol response and tolerability. The maximum recommended dose is 80 mg daily, though this higher dose is reserved for patients who cannot achieve cholesterol goals with lower doses and have been on 80 mg for at least 12 months without muscle toxicity. Dosage adjustments may be necessary for patients with kidney impairment or those taking interacting medications. All dosing decisions should be individualized by a healthcare provider based on the patient’s specific medical condition, response to treatment, and risk factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lovastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/lovastatin-3/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Aerobic Exercise Reverses Age-Related Hippocampal Shrinkage in Older Adults

A 12-month aerobic exercise trial published in PNAS reversed age-related hippocampal shrinkage…

How muscle contraction clears blood glucose independently of insulin after meals

Skeletal muscle activates a second glucose-clearance pathway during physical activity that operates…

Why Spinach Iron Doesn’t Count Like Meat Iron: The Bioavailability Gap

A cup of spinach contains 6 mg of iron but only 2–20%…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Fluvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Lovastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Simvastatin

By
Prof. Giorgi Pkhakadze
01/06/2026

Lovastatin

By
Prof. Giorgi Pkhakadze
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up